Fortis Home Health & Hospice Appoints Rob Radics as Chief Executive Officer

0
211

NEW YORK– Fortis Home Health & Hospice (“Fortis” or the “Company”), a leading home-based care company and portfolio company of lower middle market healthcare-focused private equity firm, Grant Avenue Capital, LLC (“Grant Avenue”), today announced that Rob Radics has joined the Company as Chief Executive Officer.

A seasoned executive with nearly three decades of experience leading and operating home health and hospice businesses, Mr. Radics most recently served as President, Home Health & Hospice of Aveanna Healthcare, where he managed a $250 million annual budget for 92 locations across 15 states and oversaw the completion of five acquisitions. He will leverage his deep industry experience, strong leadership skills, and track record of successfully scaling home-based care businesses to accelerate the growth of Fortis.

“We are thrilled to welcome Rob to the Fortis team at this important point in the Company’s evolution,” said Buddy Gumina, Founder and Managing Partner of Grant Avenue. “His extensive home-based care background, commitment to clinical excellence, and proven leadership will help advance Fortis’ mission of building a leading home-based care company that is renowned for its outstanding patient care and dedicated workforce. With Rob at the helm, we look forward to accelerating the expansion of Fortis through continued investment in its clinical and leadership teams, as well as strategic acquisitions, partnerships, and de novo launches.”

“Grant Avenue has strategically cemented Fortis’ position as a high-integrity, experienced provider of choice for patients and families, and as a partner of choice for our talented Fortis team. I am incredibly proud to join the Company as it embarks on its next phase of growth and advancement,” added Mr. Radics.

Prior to Aveanna Healthcare, Mr. Radics was Chief Executive Officer of Five Points Healthcare, a leading provider of home healthcare and hospice services, which he founded in 2011 and sold to Aveanna in 2020. Earlier in his career, he held multiple leadership roles at Gentiva Health Services and its predecessor company Heathfield, Inc.